Cancer Immunotherapy Is More Than a Numbers Game

See allHide authors and affiliations

Science  06 Oct 2006:
Vol. 314, Issue 5796, pp. 68-69
DOI: 10.1126/science.1133893

You are currently viewing the summary.

View Full Text


White blood cells that are genetically engineered to destroy human melanoma prove effective for a few patients in a clinical trial. A variety of strategies might increase the success rate.